Subcutaneous injection of inotersen for hereditary amyloidosis therapy in specialized care settings. Used by rheumatologists and infusion centers for polyneuropathy management. Manufactured by biotech firms and distributed to hospitals and specialty pharmacies through controlled supply networks.